🚀 VC round data is live in beta, check it out!
Cronos Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cronos Group and similar public comparables like Trulieve Cannabis, Tilray Brands, Glass House Brands, Vireo Growth and more.
Cronos Group Overview
About Cronos Group
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Founded
2012
HQ
Employees
459
Website
Financials (LTM)
EV
$191M
Cronos Group Financials
Cronos Group reported last 12-month revenue of $158M and EBITDA of $6M.
In the same LTM period, Cronos Group generated $70M in gross profit, $6M in EBITDA, and $3M in net income.
Revenue (LTM)
Cronos Group P&L
In the most recent fiscal year, Cronos Group reported revenue of $147M and EBITDA of $1M.
Cronos Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $158M | XXX | $147M | XXX | XXX | XXX |
| Gross Profit | $70M | XXX | $63M | XXX | XXX | XXX |
| Gross Margin | 44% | XXX | 43% | XXX | XXX | XXX |
| EBITDA | $6M | XXX | $1M | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 1% | XXX | XXX | XXX |
| EBIT Margin | (7%) | XXX | (12%) | XXX | XXX | XXX |
| Net Profit | $3M | XXX | ($9M) | XXX | XXX | XXX |
| Net Margin | 2% | XXX | (6%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cronos Group Stock Performance
Cronos Group has current market cap of $1B, and enterprise value of $191M.
Market Cap Evolution
Cronos Group's stock price is $2.69.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $191M | $1B | 0.8% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCronos Group Valuation Multiples
Cronos Group trades at 1.2x EV/Revenue multiple, and 33.2x EV/EBITDA.
EV / Revenue (LTM)
Cronos Group Financial Valuation Multiples
As of April 18, 2026, Cronos Group has market cap of $1B and EV of $191M.
Equity research analysts estimate Cronos Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cronos Group has a P/E ratio of 363.1x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $191M | XXX | $191M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 33.2x | XXX | 163.6x | XXX | XXX | XXX |
| EV/EBIT | (17.8x) | XXX | (11.0x) | XXX | XXX | XXX |
| EV/Gross Profit | 2.7x | XXX | 3.0x | XXX | XXX | XXX |
| P/E | 363.1x | XXX | (108.1x) | XXX | XXX | XXX |
| EV/FCF | 29.7x | XXX | (2010.6x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cronos Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cronos Group Margins & Growth Rates
Cronos Group's revenue in the last 12 month grew by 22%.
Cronos Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Cronos Group's rule of 40 is 36% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cronos Group's rule of X is 76% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Cronos Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 22% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Margin | 4% | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | 243% | XXX | 1328% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 36% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 76% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 14% | XXX | 15% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 28% | XXX | 33% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 56% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cronos Group Public Comps
See public comps and valuation multiples for other Cannabis comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cronos Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Trulieve Cannabis | XXX | XXX | XXX | XXX | XXX | XXX |
| Tilray Brands | XXX | XXX | XXX | XXX | XXX | XXX |
| Glass House Brands | XXX | XXX | XXX | XXX | XXX | XXX |
| Vireo Growth | XXX | XXX | XXX | XXX | XXX | XXX |
| Green Thumb Industries | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cronos Group M&A Activity
Cronos Group acquired XXX companies to date.
Last acquisition by Cronos Group was on XXXXXXXX, XXXXX. Cronos Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cronos Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCronos Group Investment Activity
Cronos Group invested in XXX companies to date.
Cronos Group made its latest investment on XXXXXXXX, XXXXX. Cronos Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cronos Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cronos Group
| When was Cronos Group founded? | Cronos Group was founded in 2012. |
| Where is Cronos Group headquartered? | Cronos Group is headquartered in Canada. |
| How many employees does Cronos Group have? | As of today, Cronos Group has over 459 employees. |
| Who is the CEO of Cronos Group? | Cronos Group's CEO is Michael Gorenstein. |
| Is Cronos Group publicly listed? | Yes, Cronos Group is a public company listed on Nasdaq. |
| What is the stock symbol of Cronos Group? | Cronos Group trades under CRON ticker. |
| When did Cronos Group go public? | Cronos Group went public in 2016. |
| Who are competitors of Cronos Group? | Cronos Group main competitors are Trulieve Cannabis, Tilray Brands, Glass House Brands, Vireo Growth. |
| What is the current market cap of Cronos Group? | Cronos Group's current market cap is $1B. |
| What is the current revenue of Cronos Group? | Cronos Group's last 12 months revenue is $158M. |
| What is the current revenue growth of Cronos Group? | Cronos Group revenue growth (NTM/LTM) is 22%. |
| What is the current EV/Revenue multiple of Cronos Group? | Current revenue multiple of Cronos Group is 1.2x. |
| Is Cronos Group profitable? | Yes, Cronos Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cronos Group? | Cronos Group's last 12 months EBITDA is $6M. |
| What is Cronos Group's EBITDA margin? | Cronos Group's last 12 months EBITDA margin is 4%. |
| What is the current EV/EBITDA multiple of Cronos Group? | Current EBITDA multiple of Cronos Group is 33.2x. |
| What is the current FCF of Cronos Group? | Cronos Group's last 12 months FCF is $6M. |
| What is Cronos Group's FCF margin? | Cronos Group's last 12 months FCF margin is 4%. |
| What is the current EV/FCF multiple of Cronos Group? | Current FCF multiple of Cronos Group is 29.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.